| PERIOD ENDING | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 31,393 | 29,766 | 28,548 | 26,873 | | Cost of Revenue | 19,395 | 17,833 | 18,495 | 16,296 | | | Gross Profit | 11,998 | 11,933 | 10,053 | 10,577 | | | Operating Expenses | | Research Development | 2,146 | 2,488 | 3,097 | 2,824 | | Selling General and Administrative | 10,344 | 10,797 | 15,399 | 14,974 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (492) | (1,352) | (8,443) | (7,221) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 362 | (8) | (186) | (18) | | Earnings Before Interest And Taxes | (130) | (1,360) | (8,629) | (7,239) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (130) | (1,360) | (8,629) | (7,239) | | Income Tax Expense | (510) | (465) | (2,564) | (3,230) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 380 | (895) | (6,065) | (4,009) | | | Non-recurring Events | | Discontinued Operations | 6,758 | 430 | (18,881) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,138 | (465) | (24,946) | (4,009) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,138 | ($465) | ($24,946) | ($4,009) |
|
0.17% Nasdaq 
0.14 (4.02%) 
Income Statement
